AU783373B2 - Epithelial cell growth inhibitors - Google Patents

Epithelial cell growth inhibitors Download PDF

Info

Publication number
AU783373B2
AU783373B2 AU60523/00A AU6052300A AU783373B2 AU 783373 B2 AU783373 B2 AU 783373B2 AU 60523/00 A AU60523/00 A AU 60523/00A AU 6052300 A AU6052300 A AU 6052300A AU 783373 B2 AU783373 B2 AU 783373B2
Authority
AU
Australia
Prior art keywords
prostate
cells
unsure
protein
ecgi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60523/00A
Other languages
English (en)
Other versions
AU6052300A (en
Inventor
Paul R. Ervin Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotherapies Inc
Original Assignee
Biotherapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotherapies Inc filed Critical Biotherapies Inc
Publication of AU6052300A publication Critical patent/AU6052300A/en
Application granted granted Critical
Publication of AU783373B2 publication Critical patent/AU783373B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU60523/00A 1999-06-18 2000-06-19 Epithelial cell growth inhibitors Ceased AU783373B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13999599P 1999-06-18 1999-06-18
US60/139995 1999-06-18
PCT/US2000/016900 WO2000078955A1 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Publications (2)

Publication Number Publication Date
AU6052300A AU6052300A (en) 2001-01-09
AU783373B2 true AU783373B2 (en) 2005-10-20

Family

ID=22489251

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60523/00A Ceased AU783373B2 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Country Status (13)

Country Link
EP (1) EP1190054A1 (de)
JP (1) JP2003513615A (de)
KR (1) KR20020016837A (de)
CN (1) CN1399680A (de)
AU (1) AU783373B2 (de)
BR (1) BR0012301A (de)
CA (1) CA2375498A1 (de)
IL (1) IL147148A0 (de)
MX (1) MXPA01013242A (de)
NZ (1) NZ516545A (de)
PL (1) PL352997A1 (de)
WO (1) WO2000078955A1 (de)
ZA (1) ZA200200145B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
AU2000257514A1 (en) * 2000-06-19 2002-01-02 The University Of Michigan Mammastatin sequence variant c
CN102787094B (zh) * 2011-05-17 2015-09-23 李晖 培养基、细胞培养用试剂盒及细胞培养方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
WO1998014577A2 (en) * 1996-10-03 1998-04-09 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
WO1999032625A2 (en) * 1997-12-19 1999-07-01 The University Of Michigan Nucleotide and protein sequence of mammastatin and methods of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
WO1998014577A2 (en) * 1996-10-03 1998-04-09 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
WO1999032625A2 (en) * 1997-12-19 1999-07-01 The University Of Michigan Nucleotide and protein sequence of mammastatin and methods of use

Also Published As

Publication number Publication date
KR20020016837A (ko) 2002-03-06
AU6052300A (en) 2001-01-09
NZ516545A (en) 2004-06-25
IL147148A0 (en) 2002-08-14
MXPA01013242A (es) 2002-11-04
WO2000078955A1 (en) 2000-12-28
EP1190054A1 (de) 2002-03-27
JP2003513615A (ja) 2003-04-15
ZA200200145B (en) 2003-04-30
CA2375498A1 (en) 2000-12-28
BR0012301A (pt) 2002-03-26
WO2000078955A9 (en) 2002-09-06
PL352997A1 (en) 2003-09-22
CN1399680A (zh) 2003-02-26

Similar Documents

Publication Publication Date Title
US8071716B2 (en) Thymus-specific protein
AU2013213873B2 (en) Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis
KR20100017494A (ko) 프로테오글리칸 폴리펩타이드를 암호화하는 핵산을 이용한 상처 및 피부손상의 치료
US11628206B2 (en) Method for inhibiting STAT3 activity comprising administering Ssu72
CN107629114B (zh) 多肽、其衍生物及其在制备抗肺纤维化的药物中的应用
AU783373B2 (en) Epithelial cell growth inhibitors
WO1998022505A1 (fr) Polypeptides solubles
JP2729712B2 (ja) 機能性ポリペプチド
JP2001527402A (ja) Ｎｇｆ変異体
KR100256664B1 (ko) 단백질 p140의 신규 폴리펩티드 및 그를 암호하는 dna
KR102460983B1 (ko) 새로운 재생 치료제로서의 camkk1
US20030157576A1 (en) Epithelial cell growth inhibitors
EP1237910B1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
AU759409B2 (en) Preventives and/or remedies for obesity
CN116789751B (zh) 预防和/或治疗纤维化疾病的多肽及其应用
KR102638021B1 (ko) 섬유질환 예방 또는 치료용 재조합 융합 단백질
DE60217711T2 (de) Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase
CN111574590B (zh) 一种具有抗肿瘤功能的多肽及其应用
US9371523B2 (en) Cell migration regulator
JP2002509693A (ja) カドヘリン由来成長因子及びその使用
EP0686194A1 (de) Wachtumsfaktor aus der harp-reihe, verfahren zu ihrer herstellung und verwendungen davon
US7893031B2 (en) Neuronal differentiation inhibitor peptide and use thereof
KR20120095063A (ko) ＩＬ-27로 유도된 ｐ53을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
KR20210127618A (ko) 섬유질환 예방 또는 치료용 재조합 융합 단백질
WO2005065702A1 (ja) ＧＰＲ１０３－ｌｉｋｅ受容体蛋白質に対するリガンドの新規用途